In a compelling narrative that underscores the importance of genetic awareness in cancer prevention, Lisa Craven, a resident of Rumson, has taken significant steps to safeguard her health following the discovery of a high genetic risk for breast cancer. By undergoing a preventive double mastectomy—an operation designed to remove breast tissue before cancer can develop—she not only reduced her risk but also aims to inspire others to explore their genetic predispositions. This story highlights the critical intersection of genetics, proactive health measures, and patient advocacy in the fight against breast cancer.

The Power of Genetic Testing

Lisa's journey began with a routine consultation with her gynecologist regarding hormone replacement therapy (HRT) for perimenopausal symptoms. Recognizing the potential risk of breast cancer associated with some HRT options, her doctor recommended genetic testing to assess her risk level. The results were startling: Lisa's genetic assessment revealed a greater than 40% chance of developing breast cancer in her lifetime. As genetic counselors and oncologists increasingly advocate for genetic testing, Lisa's experience exemplifies how such assessments can empower patients to make informed decisions about their health. The genetic panel she underwent tested for key mutations, including BRCA1, BRCA2, and PALB2, which are known to significantly increase the risk of breast cancer. Her proactive approach not only alleviated her fears but also set the stage for decisive action.

Choosing Preventive Surgery

After consulting with Dr. Manpreet Kohli, a breast surgeon at Monmouth Medical Center, Lisa was presented with several options for managing her elevated risk. These included regular surveillance through imaging, chemoprevention with medications like tamoxifen, and the option she ultimately chose: a preventive double mastectomy. This surgery, which removes both breasts, is a significant step that many women consider when faced with high genetic risks. The decision to undergo such a procedure is deeply personal and often accompanied by emotional complexities. Lisa's choice was driven by the desire to eliminate the constant anxiety of waiting for a cancer diagnosis. "It was not a matter of if, but when," she expressed, emphasizing the relief she felt after taking control of her health.

Advocacy and Raising Awareness

Following her surgery, Lisa has become a passionate advocate for genetic testing and awareness. She believes that many women remain unaware of the options available to them and the potential benefits of early detection and prevention. By sharing her story, she hopes to encourage women to discuss genetic testing with their healthcare providers and take proactive measures regarding their breast health. Lisa's advocacy is particularly poignant given her personal experience with loss; she lost a close friend to breast cancer shortly before her own surgery. This experience fueled her desire to help others navigate their health journeys and to promote the message that knowledge is power. "Women can empower themselves with the knowledge they are doing all they can to stay healthy," she stated, highlighting the importance of informed decision-making in healthcare.

The Role of AI in Cancer Risk Assessment

The advancements in artificial intelligence (AI) are revolutionizing cancer research and risk assessment. In Lisa's case, the High Risk Breast Cancer Assessment Program utilized cutting-edge computerized tools to calculate her risk of developing breast cancer. Such AI-driven assessments can analyze vast amounts of data, providing personalized risk evaluations that can guide treatment and preventive measures. As AI continues to evolve, it holds the potential to enhance precision oncology, enabling earlier detection and more tailored treatment plans for patients. This technology can also assist healthcare providers in identifying individuals who may benefit from genetic testing, ultimately leading to more proactive and preventive approaches in cancer care. For those interested in the intersection of AI and cancer research, resources like [CureCancerWithAi.com](https://www.curecancerwithai.com) offer valuable insights into ongoing developments in this field.

Conclusion

Lisa Craven's journey from fear to empowerment serves as a powerful reminder of the importance of genetic testing and proactive health measures in the fight against breast cancer. Her story illustrates how awareness and informed choices can significantly impact one's health trajectory. By sharing her experience, Lisa not only advocates for herself but also for countless others who may be facing similar challenges. As the landscape of cancer treatment continues to evolve with innovations in genetics and AI, it is crucial for patients, caregivers, and advocates to stay informed. Resources available through platforms like [CureCancerWithAi.com](https://www.curecancerwithai.com) can help individuals navigate the complexities of cancer research and treatment options. With continued advocacy and awareness, more individuals can take charge of their health, potentially preventing cancer before it starts.

Readers who want more plain-language context on AI and oncology can also explore the Cure Cancer With AI blog and learn more about the project.